WEDNESDAY, April 17, 2024 (HealthDay News) — Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday. First approved to treat obesity by the U.S. Food and Drug Administration lastContinue Reading
WEDNESDAY, April 10, 2024 (HealthDay News) — Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight. There were concerns that longer term use of the drugs might raise users’ odds for thyroid cancer, but a Swedish study ofContinue Reading
FRIDAY, April 5, 2024 (HealthDay News) — Obese folks are less likely to benefit from a nerve-stimulation treatment for sleep apnea that’s recently been made available to them, a new study reports. The treatment is likely to be 75% less effective among obese people with BMIs of 32 to 35,Continue Reading
THURSDAY, April 4, 2024 (HealthDay News) — Two newly discovered genetic variations can have a powerful effect on a person’s risk for obesity, a new report says. Variants in the gene BSN, also known as Bassoon, can increase risk of obesity as much as sixfold, researchers report April 4 inContinue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — Research into germs that travel through the human digestive tract shows that some may promote obesity while others might help prevent it. Not only that, but those microbes may act differently in men versus women, the same study found. “Our findings reveal howContinue Reading
TUESDAY, April 2, 2024 (HealthDay News) — The seeds of high blood pressure in adulthood might be sown in youth, a new study suggests. Children and teenagers with excess weight were more likely to have high blood pressure in middle age, researchers report. In fact, there’s a linear relationship betweenContinue Reading
FRIDAY, March 29, 2024 (HealthDay News) — People taking weight-loss drugs like Ozempic and Wegovy need to drop them in the days or weeks prior to surgery, a new study warns. Folks on one of these drugs — known as GLP-1 receptor agonists — have a 33% higher risk ofContinue Reading
FRIDAY, March 29, 2024 (HealthDay News) — Children who are obese face double the odds of developing multiple sclerosis later in life, a new study warns. The overall odds for any one child to develop the neurodegenerative illness remains very low. However, the Swedish researchers believe the link could helpContinue Reading
WEDNESDAY, March 27, 2024 (HealthDay News) — Some folks struggling with obesity appear to be hampered by their own genes when it comes to working off those extra pounds, a new study finds. People with a higher genetic risk of obesity have to exercise more to avoid becoming unhealthily heavy,Continue Reading
FRIDAY, March 22, 2024 (HealthDay News) — Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday. The move comes after the U.S. Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label earlierContinue Reading